Anas Hamad

6PUBLICATIONS
23CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Social determinants of healthMolecular targetsMedical molecular engineering of nucleic acids and proteinsAfrican languages
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|May 06, 2026
Expert consensus on the role of immunotherapy in nasopharyngeal carcinoma: clinical and economic perspectives from the GCC region.

|Apr 17, 2026
Childhood immunization barriers and interventions in low- and middle-income countries: A scoping review of access, delivery systems, and health literacy.

|Feb 23, 2026
Economic evaluation of cyclin-dependent kinases 4 and 6 inhibitors in advanced hormonal receptor-positive and human epidermal growth factor receptor 2 negative breast cancer: a nationwide budget impact analysis.

Shereen Elazzazy, Nour Hisham Al-Ziftawi, Laila Shafei

|Dec 30, 2025
The Cost of Resource Use Relative to the Development of the Antimicrobial Stewardship Program in a Tertiary Cancer Setting in Qatar.

Dina Abushanab, Diala Alhaj Moustafa, Anas Hamad

|Oct 31, 2024
Expert Consensus Recommendations on a Biosimilars Value Framework for the Gulf Cooperation Council Countries.

Khalid A Alnaqbi, Ahmed Al-Jedai, Mohamed Farghaly

|Jan 08, 2023
Cost-Effectiveness and Cost-Utility of Palbociclib versus Ribociclib in Women with Stage IV Breast Cancer: A Real-World Data Evaluation.

Nour Hisham Al-Ziftawi, Mohammed Fasihul Alam, Shereen Elazzazy

Pageof 1

Frequent Collaborators

2 joint publications

Shereen Elazzazy

2 joint publications

Mohamed Izham Mohamed Ibrahim

1 joint publications

Nour Hisham Al-Ziftawi

1 joint publications

Asrul Akmal Shafie